BioNTech SE (BNTX) Consolidated Net Income (2018 - 2026)
BioNTech SE (BNTX) posted Consolidated Net Income of -$1.04 billion for Q2 2026, compared with -$474.06 million a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) Consolidated Net Income (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at BioNTech SE was -$2.14 billion; for FY2025, it came in at -$1.32 billion.
- In prior years, BioNTech SE's Consolidated Net Income was -$710.94 million in FY2024, $1 billion in FY2023 (-89.6%), $9.63 billion in FY2022 (-18.3%) and $11.77 billion in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Consolidated Net Income in data going back to Q3 2018.
- The strongest year-over-year quarter for Consolidated Net Income in the past five years was Q4 2021, with growth of 728.0%; the weakest was Q3 2023, with a decline of 90.3%.
- According to Business Quant data, Consolidated Net Income for the three prior quarters was -$707.48 million (Q1 2026), -$355.03 million (Q4 2025) and -$33.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -237.00 Mn |
| 10 | BioNTech SE | 24.49 Bn | -34.88 Bn | 10.00 Mn | -1.04 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.04 Bn |
| Mar 31, 2026 | -707.48 Mn |
| Dec 31, 2025 | -355.03 Mn |
| Sep 30, 2025 | -33.55 Mn |
| Jun 30, 2025 | -474.06 Mn |
| Mar 31, 2025 | -499.65 Mn |
| Dec 31, 2024 | 277.30 Mn |
| Sep 30, 2024 | 217.56 Mn |
| Jun 30, 2024 | -869.91 Mn |
| Mar 31, 2024 | -342.31 Mn |
| Dec 31, 2023 | 492.67 Mn |
| Sep 30, 2023 | 174.83 Mn |
| Jun 30, 2023 | -207.33 Mn |
| Mar 31, 2023 | 539.03 Mn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 4.15 Bn |
| Dec 31, 2021 | 3.62 Bn |
| Sep 30, 2021 | 3.79 Bn |
API Access
BioNTech SE Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();